AU2001278135A1 - Method of identifying immunosuppressive agents - Google Patents

Method of identifying immunosuppressive agents

Info

Publication number
AU2001278135A1
AU2001278135A1 AU2001278135A AU7813501A AU2001278135A1 AU 2001278135 A1 AU2001278135 A1 AU 2001278135A1 AU 2001278135 A AU2001278135 A AU 2001278135A AU 7813501 A AU7813501 A AU 7813501A AU 2001278135 A1 AU2001278135 A1 AU 2001278135A1
Authority
AU
Australia
Prior art keywords
immunosuppressive agents
identifying immunosuppressive
identifying
agents
immunosuppressive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278135A
Inventor
Douglas R. Green
Shailaja Kasibhatla
Ben Tseng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytovia Therapeutics LLC
Original Assignee
Cytovia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytovia Inc filed Critical Cytovia Inc
Publication of AU2001278135A1 publication Critical patent/AU2001278135A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
AU2001278135A 2000-08-03 2001-08-02 Method of identifying immunosuppressive agents Abandoned AU2001278135A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22289700P 2000-08-03 2000-08-03
US60/222,897 2000-08-03
PCT/US2001/024250 WO2002012545A2 (en) 2000-08-03 2001-08-02 Method of identifying immunosuppressive agents

Publications (1)

Publication Number Publication Date
AU2001278135A1 true AU2001278135A1 (en) 2002-02-18

Family

ID=22834184

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278135A Abandoned AU2001278135A1 (en) 2000-08-03 2001-08-02 Method of identifying immunosuppressive agents

Country Status (3)

Country Link
US (1) US6828091B2 (en)
AU (1) AU2001278135A1 (en)
WO (1) WO2002012545A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342611B1 (en) * 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
US7053117B2 (en) * 2001-05-16 2006-05-30 Cytovia, Inc. Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
AU2001278135A1 (en) 2000-08-03 2002-02-18 Cytovia, Inc. Method of identifying immunosuppressive agents
AU2003230411A1 (en) 2002-05-16 2003-12-02 Cytovia, Inc. Substituted 4-aryl-4h-pyrrolo(2,3-h)chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2003096982A2 (en) * 2002-05-16 2003-11-27 Cytovia, Inc. Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof
US7067266B2 (en) * 2002-07-10 2006-06-27 Rigel Pharmaceuticals, Inc. Modulators of leukocyte activation, Hck compositions and methods of use
WO2005100553A2 (en) * 2004-04-16 2005-10-27 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for assessment of cytotoxic lymphocyte activity
CN101289482B (en) 2007-09-29 2011-08-31 辽宁利锋科技开发有限公司 Cambogic acid glycoside derivates and the like, preparation and uses thereof
PT2278960T (en) 2008-03-17 2017-03-09 Actelion Pharmaceuticals Ltd Dosing regimen for a selective sip1 receptor agonist
KR101821118B1 (en) 2016-09-06 2018-01-23 가톨릭대학교 산학협력단 Composition for Preventing or Treating Allergic Disease Comprising Gambogic Acid

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336186A (en) 1978-08-03 1982-06-22 Gargiulo Robert J Analytical fluorogenic substrates for proteolytic enzymes
US4557862A (en) 1983-10-28 1985-12-10 University Patents, Inc. Rhodamine derivatives as fluorogenic substrates for proteinases
US4640893A (en) 1983-10-28 1987-02-03 University Of Illinois Novel rhodamine derivatives as fluorogenic substrates for proteinases
US4900686A (en) 1987-04-02 1990-02-13 Polaroid Corporation Fluorescent conjugates and biological diagnostic assay
US5227487A (en) 1990-04-16 1993-07-13 Molecular Probes, Inc. Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes
US5587490A (en) 1990-04-16 1996-12-24 Credit Managers Association Of California Method of inactivation of viral and bacterial blood contaminants
US5208148A (en) 1990-12-07 1993-05-04 Molecular Probes, Inc. Lipophilic fluorescent glycosidase substrates
ATE180018T1 (en) 1991-08-23 1999-05-15 Molecular Probes Inc USE OF HALOALKYL DERIVATIVES OF REPORTER MOLECULES FOR ANALYZING METABOLIC ACTIVITY IN CELLS
US5316906A (en) 1991-08-23 1994-05-31 Molecular Probes, Inc. Enzymatic analysis using substrates that yield fluorescent precipitates
US5576424A (en) 1991-08-23 1996-11-19 Molecular Probes, Inc. Haloalkyl derivatives of reporter molecules used to analyze metabolic activity in cells
WO1993010461A1 (en) 1991-11-12 1993-05-27 Promega Corporation Non-radioactive enzyme assay
US5696128A (en) 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
EP0623599A1 (en) 1993-03-26 1994-11-09 Ciba-Geigy Ag Optical sensors for the determination of cations
US6087160A (en) 1993-06-24 2000-07-11 The General Hospital Corporation Programmed cell death genes and proteins
US5659024A (en) 1994-01-14 1997-08-19 The Burnham Institute Promotors that regulate the expression of genes involved in cell death
US5556992A (en) 1994-09-02 1996-09-17 Universite De Montreal Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias
US5605809A (en) 1994-10-28 1997-02-25 Oncoimmunin, Inc. Compositions for the detection of proteases in biological samples and methods of use thereof
US5843635A (en) 1995-02-27 1998-12-01 Dana-Farber Cancer Institute, Inc. Inhibition of APC-mediated apoptosis of activated T lymphocytes
US5733719A (en) 1995-05-18 1998-03-31 Coulter Corporation Method of making an assay compound
US5698411A (en) 1995-05-18 1997-12-16 Coulter Corporation Method for determining activity of enzymes in metabolically active whole cells
US5976822A (en) 1995-05-18 1999-11-02 Coulter International Corp. Method and reagent for monitoring apoptosis and distinguishing apoptosis from necrosis
US5776720A (en) 1995-05-18 1998-07-07 Coulter Corporation Assay reagent
US5871946A (en) 1995-05-18 1999-02-16 Coulter Corporation Method for determining activity of enzymes in metabolically active whole cells
US5834216A (en) 1995-09-06 1998-11-10 Arch Development Corporation Screening methods for the identification of inducers and inhibitors of programmed cell death (apoptosis)
US6200969B1 (en) 1996-09-12 2001-03-13 Idun Pharmaceuticals, Inc. Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
US5897992A (en) 1996-09-27 1999-04-27 Cold Spring Harbor Laboratory Cell-free assay using oncogene-induced apoptosis in drug-resistant cells
US6077684A (en) 1996-11-14 2000-06-20 Vanderbilt University Automated assay for measuring apoptosis in cell culture
US5773236A (en) 1997-04-25 1998-06-30 Molecule Probes, Inc. Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules
US6270980B1 (en) 1997-06-05 2001-08-07 Idun Pharmaceuticals, Inc. Rapid methods for identifying modifiers of cellular apoptosis activity
WO1998057664A1 (en) 1997-06-19 1998-12-23 The General Hospital Corporation Interleukin converting enzyme (ice) and central nervous system damage
US6342611B1 (en) 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
HUP0100079A2 (en) 1997-10-10 2001-05-28 Cytovia, Inc. Novel fluorescent reporter molecules and their applications including assays for caspases
AU5116099A (en) 1998-07-21 2000-02-14 Sui Xiong Cai Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof
WO2000007017A2 (en) 1998-07-27 2000-02-10 President And Fellows Of Harvard College Method of high-throughput screening
AU2864100A (en) 1999-02-01 2000-08-18 Cytovia, Inc. Methods of identifying therapeutically effective antineoplastic agents with cultured cells having intact cell membranes and corresponding products
CA2406271A1 (en) 2000-04-18 2001-10-25 Cytovia, Inc. Substituted 1,4-thiazepine and analogs and their use as activators of caspases
AU2001278135A1 (en) 2000-08-03 2002-02-18 Cytovia, Inc. Method of identifying immunosuppressive agents
WO2002099378A2 (en) 2001-06-01 2002-12-12 Cytovia, Inc. Methods of identifying anti-cancer agents that are inducers of apoptosis

Also Published As

Publication number Publication date
US6828091B2 (en) 2004-12-07
WO2002012545A2 (en) 2002-02-14
US20020076733A1 (en) 2002-06-20
WO2002012545A3 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
AU2001249981A1 (en) Method of payroll access
AU2001271940A1 (en) Distributed search system and method
AU2001261566A1 (en) Well service composition and method
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2001238696A1 (en) Method of reducing defects
AU7078100A (en) Methods of identifying anti-viral agents
AU2000276782A1 (en) Spray-spin coating method
AU2001279850A1 (en) Method and arrangement for studsystem
AU2001281269A1 (en) Search system and method
AU2001281633A1 (en) Detection method
AU2001243394A1 (en) Compounds and methods
AU2001267978A1 (en) Method for analyzing words
AU2001278135A1 (en) Method of identifying immunosuppressive agents
AUPR050700A0 (en) Detection method
AU2001271841A1 (en) Methods for identifying combinations of drugs
AUPQ667800A0 (en) Detection method
AUPQ872300A0 (en) Compounds and methods
AU2001290313A1 (en) Service providing method
AU5650401A (en) Method for enhancing cognitive function
AU2001278951A1 (en) Compounds and methods
AU2001237530A1 (en) Method
AU2002246912A1 (en) Receptor-binding compounds and methods for identifying them
AU2001241636A1 (en) Halotherapy method
AU2002235277A1 (en) Compounds and methods